Jamie Christensen - May 24, 2021 Form 4 Insider Report for Mirati Therapeutics, Inc. (MRTX)

Role
EVP, Chief Scientific Officer
Signature
/s/ Vickie Reed, Attorney-in-Fact
Stock symbol
MRTX
Transactions as of
May 24, 2021
Transactions value $
-$67,138
Form type
4
Date filed
5/25/2021, 06:04 PM
Next filing
Dec 7, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRTX Common Stock Sale -$67.1K -435 -0.8% $154.34 53.9K May 24, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold by the Company to satisfy the tax withholding obligation associated with the vesting of a portion of the restricted stock units (RSUs) granted on May 21, 2020.